Advancing Genomic Profiling in Myeloproliferative Neoplasms (MPN) with Next Generation Sequencing

This educational webinar explores advances in genomic profiling of myeloproliferative neoplasms (MPNs) and how molecular testing strategies are evolving from traditional sequential PCR testing toward broader next-generation sequencing (NGS) approaches.

The presentation reviews key MPN driver mutations, diagnostic workflows, and the significance of additional co-mutations that influence prognosis and disease progression. It also discusses how integrating molecular technologies may improve detection of low-frequency variants and provide broader insight into the mutational landscape of myeloid malignancies.

Topics include the role of genomic testing in:
• Establishing clonality in suspected myeloproliferative neoplasms
• Identifying driver mutations such as JAK2, CALR, and MPL
• Detecting additional mutations associated with prognosis or therapy response
• Understanding triple-negative MPN cases
• Comparing sequential PCR testing and NGS panel-based testing strategies
• Integrating molecular data into diagnostic and clinical workflows

Learn more about how NGS enables rapid MPN Genomic Profiling: https://www.thermofisher.com/us/en/home/clinical/preclinical-companion-diagnostic-development/oncomine-oncology/education/myeloproliferative-neoplasm-profiling-ngs.html?cid=youtube

Intended for US healthcare and laboratory professionals. For educational purposes only.

Видео Advancing Genomic Profiling in Myeloproliferative Neoplasms (MPN) with Next Generation Sequencing канала Thermo Fisher Scientific